Breaking diagnostic boundaries with speed, comfort and confidence
For many years physicists, radiology managers and others working in MR have sought to find a way to become less reliant on helium.
For C-suite, sustainability is an integral part of managing a healthcare organisation’s productivity and total cost of ownership. It’s not about looking for short-term gains; it’s about finding long-term solutions to drive efficiency and lower costs while providing outstanding care to patients.
Philips is committed to understanding the challenges facing clinicians today, and providing solutions to assist in the delivery of a confident diagnosis the first time.
Unprecedented access to deep insights into the patients behind the image has allowed Philips to develop new Ingenia integrated MR solutions. These solutions are breaking down diagnostic boundaries by delivering speed, comfort and confidence, all with the aim of improving patient care.
Most recently, Philips introduced the next MR wave — Ingenia Elition, a new 3.0T MR, and the Ingenia Ambition, a new 1.5T MR, in Australia and New Zealand. These solutions provide leading-edge MR capabilities with integrated systems, helping to elevate the patient experience, support clinical confidence and increase overall productivity.
Integrating the latest innovations in systems, software and services, the Philips Ingenia Elition MR solution offers excellent image quality and reduces the time taken to conduct patient exams by up to 50%. Leveraging AI-driven SmartExam analytics, Ingenia Elition enables automatic planning, scanning and processing of exams, helping to support a faster, smarter and simpler path to confident diagnosis and improved patient experience.
Ingenia Elition’s VitalScreen offers operators fully guided patient set-up with a newly designed user interface for workflow optimisation, and VitalEye enables unique patient sensing and breathing approach. VitalEye technology and algorithms intelligently extract signs of breathing — allowing routine exam set-up time to occur in less than a minute.
The Philips Ingenia Ambition provides leading-edge MR capabilities while helping to increase overall productivity. Built around the breakthrough BlueSeal magnet, the Ingenia Ambition is the industry’s first MR system to enable helium-free operations, reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply. The fully sealed system does not require a vent pipe and is approximately 900 kg lighter than its predecessor, significantly reducing the siting challenges presented by conventional magnets and lowering construction costs.
The Ingenia Ambition combines guided patient set-up and AI-driven SmartExam analytics for automatic planning, scanning and processing, freeing up time to enable a single operator to manage the full scan from the patient’s side.
With MR scanners being a leading modality for healthcare organisations, innovative imaging solutions are key in supporting the delivery of seamless care and first-time-right diagnosis. Together, the new Ingenia integrated MR solutions help to standardise and speed up workflow, allowing clinicians to keep focus solely on the patient.
These innovations simplify data and insights gathering, enabling the right acquisition of the right scan for the right patient — the first time, making imaging a better experience for patients and clinicians, achieving better outcomes, and reducing the cost of imaging to support the path to value-based care.
Find out more about how Philips’ MR innovations are improving speed, comfort and confidence here.
 Using Compressed SENSE technology and compared to Philips exams without Compressed SENSE
 Based on in-house testing
 The Ingenia Ambition 1.5T contains less than 0.5% of the helium of a conventional system and this is permanently sealed inside the device
 SmartExam is not available to patients with MR Conditional Implants
Australia has ranked #40 in an index of 50 countries in a global study comparing the cost of some...
The release of new European guidelines on dyslipidaemias has called Australia’s LDL-C...
Professor Brendan Crabb received the 2019 GSK Award for Research Excellence for his research on...